Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.06M

combined est. value

Stock	Shares	Price	Value	Weight	As of
NUVLNuvalent, Inc.	8,590	$123.96	$1.06M	100%	2026-06-16

NUVL

Nuvalent, Inc.

$1.06M

8,590 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 0

Stock	Transaction	Date	~6mo later
NUVLNuvalent, Inc.	Grant — · 3,444 sh	2026-06-16	—
MRSNMersana Therapeutics, Inc.	Other — · 9,609 sh	2026-01-06	—
MRSNMersana Therapeutics, Inc.	Other — · 2,890 sh	2026-01-06	—
MRSNMersana Therapeutics, Inc.	Other — · 6,721 sh	2026-01-06	—
NUVLNuvalent, Inc.	Grant — · 2,647 sh	2025-06-18	—

NUVLGrant

2026-06-16 · Nuvalent, Inc.

3,444

—

MRSNOther

2026-01-06 · Mersana Therapeutics, Inc.

9,609

—

MRSNOther

2026-01-06 · Mersana Therapeutics, Inc.

2,890

—

MRSNOther

2026-01-06 · Mersana Therapeutics, Inc.

6,721

—

NUVLGrant

2025-06-18 · Nuvalent, Inc.

2,647

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.